AESGP. 1995. Economic and Legal Framework for Non-Prescription Medicines in Europe. Brussels: European Proprietary Medicines Manufacturer's Association (AESGP), Jun., 36-43.

Akerele, O. 1992. Summary of WHO Guidelines for the Assessment of Herbal Medicines. In HerbalGram 28: 13-16.

Anonymous. 1996. Survey Indicates Increasing Herb Use. Herbal Gram 37: 56.

Bauer, R. and H. Wagner. 1991. Echinacea species as potential immunostimulatory drugs. In Economic and Medicinal Plant Research Vol. 5. H. Wagner and N.R. Farnsworth (eds.). New York: Academic Press: 253-351.

Bayne, H., M. Blumenthal, L.D. Israelsen. 1966. A Survey of Regulations of Herbal Medicines in Six Industrialized Nations: Executive Summary. Austin, Texas: American Botanical Council.

Bergner, P. 1994. German Evaluation of Herbal Medicines. Herbal Gram 30: 17,64.

Bisset, N.G. (trans.) and Wichtl, M. 1994. Herbal Drugs and Phytopharmaceuticals . Boca Raton, Florida: CRC Press.

Blumenthal, M. 1998. Perspectives on the Safety of Herbal Medicines. In Leikin, J.B. and Paloucek, F.P. Poisoning & Toxicology Compendium . Hudson, Ohio: Lexi-Comp Inc.

Blumenthal, M. 1997. Herbal Monographs Initiated by Numerous Groups. Herbal Gram 40: 30-35, 37-38.

Blumenthal, M. 1995. Herb Sales Up 35 Percent in Mass Market. Herbal Gram 34: 66.

Blumenthal, M. 1994. Regulatory Models for Approval of Botanicals as Traditional Medicines. Presentation at "Botanicals: Role in U.S. Healthcare?" conference sponsored by the Office of Alternative Medicine, National Institutes of Health, Washington, D.C. Dec. 14.

Bradley, P. 1992. The British Herbal Compendium . Bournemouth, England: British Herbal Medicine Association.

Braunig, B., M. Dorn, E. Limburg, E. Knick. 1992. Echinacea purpurea root for strengthening the immune response in flu-like infections. Zeitschrift fur Phytotherapie 13: 7-13.

Brevoort, P. 1996. The U.S. Botanical Market — An Overview. Herbal Gram 36: 49-57.

Busse, W. 1997a. How Can Lessons Learned (and Unlearned) from Non-U.S. Markets Be Applied to the U.S. Market? Presentation at Third Drug Information Association Workshop on Botanicals: Botanical Testing: Developing the Scientific and Clinical Evidence to Support the Clinical Use of Heterogeneous Botanical Products. Washington, D.C., Jan. 27.

Busse, W. 1997b. Personal communication, Aug. 14.

Busse, W. 1997c. Personal communication, Dec. 19.

Busse, W. 1996. Personal communication, Mar. 28.

Carper, Jean. 1997. Miracle Cures. New York: Harper Collins.

Commission of European Communities. 1989. Notice to Applicants for Marketing Authorization for Medicinal Products for Human Use in the Member States of the European Community. Vol. III. Guidelines on the Quality, Safety and Efficacy of the Medicinal Products for Human Use. Jan., 1989. (Note for guidance relating to Part 1 of the Annex to Directive 75/318 EEC, as amended.)

Commission on Dietary Supplement Labels. 1997. Report to the President, the Congress, and the Secretary of Health and Human Services . Nov. 24.

Deutsches Arzneibuch . Amtlich Eausgabe. Stuttgart, Germany: Deutscher Apotheker Verlag.

Duke, J.A. 1997. The Green Pharmacy . Emmaus, Penn. Rodale Press.

De Smet, P.A.G.M. 1993. Legislatory Outlook on the Safety of Herbal Medicines. In De Smet, P.A.G.M., K. Keller, R. Hänsel, and R.F. Chandler. Adverse Effects of Herbal Drugs Vol. 2, Berlin: Springer-Verlag.

De Smet, P.A.G.M. and W.A. Nolen. 1996. St. John's Wort as an antidepressant. British Medical Journal 313: 241-247.

European Economic Community. 1975. Directive 75/318/EEC. Standards for Quality of Herbal Remedies.

Farnsworth, N.R. 1985. Siberian Ginseng ( Eleutherococcus senticosus ): Current Status as an Adaptogen. In Economic and Medicinal Plant Research, Vol. I. Wagner, H., H. Hikino, and N.R. Farnsworth (eds.). London: Academic Press.

Federal Health Agency. 1989. Evaluation Criteria for Fixed Drug Combinations. Natur- und Ganzheitsmedizin ( Complementary and Wholistic Medicine ) 6:159-160.

Food and Drug Administration. 1996. Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System; Request for Information and Comments. Advance Notice of Proposed Rulemaking. Federal Register Vol. 61, No. 193, Oct. 3: 51625-31.

Food and Drug Administration. 1993. Food Labeling: General Requirements for Health Claims for Dietary Supplements. Proposed Rule. Federal Register Vol. 58, No. 116, Jun. 18: 33700-14.

Foster, S. 1996. Personal communication, March 3.

Foster, S. (ed.) 1992. Herbs of Commerce . Austin, Texas: American Herbal Products Association.

Foster, S. 1990. Ginkgo, Ginkgo biloba . Botanical Series No. 304. American Botanical Council, Austin, Texas. p. 7.

Franz, G. 1997. Personal communication, Dec. 15.

Fresenius, W., H. Niklas and H. Schilcher. 1997. Nonprescription Medicines (Freiverkäufliche Arzneimittel. 3rd ed. Stuttgart: Wissenchaft Verlagsgesellschaft.

Fulder, S. and M. Tenne. 1996. Ginger as an Anti-nausea Remedy in Pregnancy: The Issue of Safety. Herbal Gram 38: 47-50.

Gericke, N. 1995. The Regulation and Control of Traditional Herbal Medicines. Cape Town, South Africa: Traditional Medicines Programme at the University of Cape Town.

Glovsky, S. 1998. Personal communication, Mar. 4.

Greuter, W. et al . (eds.) 1988. International Code of Botanical Nomenclature (Adopted by the 14th International Botanical Congress, Berlin, July-August, 1987). Koenigstein, Germany: Koeltz Scientific Books.

Gruenwald, J. 1998. Personal communication, Jan. 25.

Gruenwald, J. 1997. Most frequently prescribed herbal monopreparations in Germany, listed according to active ingredient and sales. Herbal Gram 39: 68.

Gruenwald, G. 1995. The European Phytomedicines Market: Figures, Trends, Analyses. Herbal Gram 34: 60-66.

Harnischfeger, G. 1996. Personal communication to Mark Blumenthal, Jun. 27.

Hocking, G.M. 1955. A Dictionary of Terms In Pharmacognosy and Other Divisions of Economic Botany. Springfield, IL: Charles C. Thomas.

IfD survey 6039. 1997. Institute for Demoscopy in Allensbach, Germany. Report on Natural Medicines — Mar. 1997.

Johnston, B. 1997. One-Third of Nation's Adults Use Herbal Remedies: Market Estimated at $3.24 Billion. HerbalGram 40: 49.

Kada, T., K. Morita, and T. Inoue. 1978. Anti-mutagenic action of vegetable factors on the mutagenic principle of tryptophan pyrolysate. Mutation Research 53: 351-353.

Keller, K. 1998a. Personal communication, Jan. 2.

Keller, K. 1998b. Personal communication, Jan. 6.

Keller, K. 1996. Herbal Medicinal Products in Germany and Europe: Experiences with National and European Assessment. Drug Information Journal , Vol. 30: 993-948.

Keller, K. 1994. Phytotherapy at a European level. European Phytotelegram , ESCOP, Aug.: 40-45.

Keller, K. 1992. Results of the revision of herbal drugs in the Federal Republic of Germany with a special focus on risk aspects. Zeitschrift für Phytotherapie 13: 116-120.

Keller, K. 1991. Legal Requirements for the use of phytopharmaceutical drugs in the Federal Republic of Germany. Journal of Ethnopharmacology 32: 225-229.

Koerner, S. 1997. Personal communication from Deutscher Apotheker Verlag to M. Blumenthal, Nov. 25.

Leung, A.Y. 1998. Personal communication, Mar. 2.

Linde, K., G. Ramirez, C.D. Mulrow, A. Pauls, W. Weidenhammer, D. Melchart. 1996. St. John's Wort for depression — an overview and meta-analysis of randomized clinical trials. British Medical Journal 313: 253-258.

Nagabhushan, M . et al . 1987. Mutagenicity of gingerol and shogaol and antimutagenicity of zingerone in Salmonella/microsome assay. Cancer Letters 36: 221-223.

Namakura, H. and T. Yamamoto. 1982. Mutagen and antimutagen in ginger, Zingiber officinale . Mutation Research 103: 119-126.

Pinco, R.G. and L.D. Israelsen. 1995. European-American Phytomedicines Coalition Citizen Petition to Amend FDA's Monograph on Antiemetic Drug Products for Over-the-Counter ("OTC") Human Use to Include Ginger. May 26.

Pinco, R.G. and L.D. Israelsen. 1994. European-American Phytomedicines Coalition Citizen Petition to Amend FDA's Monograph on Nighttime Sleep-aid Drug Products for Over-the Counter ("OTC") Human Use to Include Valerian. Jun. 7.

Pinco, R.G. and L.D. Israelsen. 1992. European-American Phytomedicines Coalition Citizen Petition to Amend FDA's OTC Drug Review Policy Regarding Foreign Ingredients. Jul. 24.

PhRMA (Pharmaceutical Research and Manufacturers of America). 1998. Information from worldwide website at http://www.phrma.org/, Mar. 19.

Richman, A. and J.P. Witkowski. 1997. Herbs by the Numbers: Whole Foods' Third Annual Natural Herbal Product Sales Survey. Whole Foods Oct.: 20-28.

Schilcher, H. 1998a. Personal communication, Feb. 9.

Schilcher, H. 1998b. The Present State of Phytotherapy in Germany. Deutsche Apotheker Zeitung 138 Jahrgang, No. 3, Jan. 15: 144-149.

Schilcher, H. 1998c. The Phytotherapy Situation in the Republic of Germany. Münchner Medizinische Wochenschrift . Feb. (in press).

Schilcher, H. 1998d. Personal communication, Apr. 1.

Schilcher, H. 1997a. Phytotherapie in Paediatrics: Handbook for Physicians and Pharmacists. Stuttgart: Medpharm Scientific Publishers.

Schilcher, H. 1997b. Personal communication, Dec. 30.

Schilcher, H. 1997c. Standards for the Discipline of Phytotherapy in Postgraduate and Continuing Education. Ärztezeitschrift für Naturheilverfahren 38: 336-341

Schilcher, H. 1996. The Status of Phytotherapy Within Specific Therapeutic Trends and Traditional Medicine. Ärztezeitschrift für Naturheilverfarhen 37(1), Jan.: 23-34.

Schilcher, H. 1991. The Importance of Phytotherapy in Medical Schools. Zeitschrift für Phytotherapie ( Journal of Phytotherapy ), Vol. 3.

Schulte, G. 1995. Letter to H. Schilcher, August 25.

Schulz, T.K., R. Hänsel, V.E. Tyler. 1997. Rational Phytotherapy: A Physician's Guide to Herbal Medicine . Berlin: Springer-Verlag.

Schwabe, U. 1997. Arzneiverordnungsreport (Prescription Drug Report) — 1997. Stuttgart: Gustav Fischer Verlag.

Steinhoff, B. 1997a. Personal communication, Dec. 12.

Steinhoff, B. 1997b. Herbal Medicines – Increasingly Preferred. Pharmazeutische Zeitung 142(49), Dec. 4: 38-43 (4412-4417).

Steinhoff, B. 1994a. Personal communication, Apr. 11.

Steinhoff, B. 1993/1994a. New Developments regarding Phytomedicines in Germany. British Journal of Phytotherapy , Vol.3, No. 4: 190-193.

Steinhoff, B. 1993/1994b. The Legal Situation of Phytomedicines in Germany. British Journal of Phytotherapy , Vol. 3, No. 2: 76-80.

Thiele, A. 1997. Averting of drug-induced risks, grade II: pharmaceuticals containing Ginkgo biloba leaves. Communication to Dr. Willmar Schwabe GmbH & Co., May 27.

Trease, G.E. and W.C. Evans. 1996. A Textbook of Pharmacognosy . London: Bailliere, Tindall and Cassell.

Tyler, V.E. 1997. "When Will There Come a Savior…?" HerbalGram 41:27,28,56.

Tyler, V.E. 1996. Personal communication, Dec. 31.

Tyler, V.E. 1994. Herbs of Choice: The Therapeutic Use of Phytomedicinals . Binghampton, NY: Pharmaceutical Products Press.

Tyler, V.E. 1992. Phytomedicines in Western Europe: Their Potential Impact on Herbal Medicine in the United States. In Kinghorn, D.I. and Balandrin, M.F. Human Medicinal Agents from Plants. Washington, D.C. American Chemical Society. Reprinted in HerbalGram 30: 24-30, 67, 68, 77.

United States Congress. Dietary Supplement Health and Education Act of 1994. Public Law 103-417, 108 Stat. 4325-4333. Oct. 25, 1994.

United States Senate Committee on Labor and Human Resources. Report on the Dietary Supplement Health and Education Act of 1994. 103-410. Oct. 8, 1994.

United States Congress. Nutrition Labeling and Education Act of 1990. Public Law 101-535. 104 Stat. 2353-2364. Nov. 8, 1990.

Viola, H., M.L. de Stein, C. Wolfman, et al . 1996. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptor-ligand with anxiolytic effects. Planta Medica 61:213-6.

Weidenfeld, H. 1996. Personal communication to R. Rister, Mar. 6.

Wiesenauer, M. 1989. Drugs for special therapies. (In German) Review. Fortschritte der Medizin, 107 (35): 741-2, 752, Dec. 10.

World Health Organization. 1991. Guidelines for the Assessment of Herbal Medicines. Geneva: WHO, in HerbalGram 28 (1993): 17-20.

103d Congress. Public Law 103-417 — Oct. 25, 1994. Dietary Supplement Health and Education Act of 1994.qxm